A once-in-a-century global pandemic has reinforced the value of the scientific advancements America’s innovative and indispensable biopharmaceutical industry makes possible.
The advancements in vaccine research and therapeutics to combat COVID-19 are built on a collaborative ecosystem driving scientific discovery. This ecosystem has shared goals: to beat COVID-19 and to prepare for the next public health crisis. The groundbreaking vaccines and therapies bring us close, but we are not done yet. Our work continues.